Kainos Group PLC

Director's Dealing • Aug 8, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2338X

Kainos Group plc

08 August 2018

08 August 2018

Kainos Group plc

("Kainos" or the "Company)

Director / PDMR Dealing

The Company was notified on the 08 August 2018, that Brendan Mooney, CEO, exercised his 2015 PSP options over 98,921 ordinary shares of £0.005 in the Company ("Ordinary Shares"), at an exercise price of £0.005 per Ordinary Share.

Brendan Mooney retained the Ordinary Shares on exercise.  

Following this notification, Brendan Mooney and his Person Closely Associated (PCA) have a reportable shareholding of 14,205,941 Ordinary Shares in the issued share capital of the Company, constituting 11.88% of the issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

Brendan Mooney

2.         

Reason for the notification

a.         

Position/status

CEO/PDMR

b.         

Initial notification

/Amendment

Initial notification

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

Kainos Group plc

b.         

LEI

213800H2PQMIF3OVZY47

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

ISIN: GB00BZ0D6727

b.         

Nature of the transaction

Exercise of 2015 PSP Options and retention of shares

c.         

Price(s) and volume(s)

Price(s)	Volume(s)
£0.005	98,921

d.         

Aggregated information

·      Aggregated volume

·      Price

N/A

e.         

Date of the transaction

08 August 2018

f.         

Place of the transaction

Outside a trading venue

Classification: Additional Regulated Information

Ends

For further information, please contact:

Kainos                                                                                         via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc                                                                                 44 20 7597 5970

Patrick Robb / Sebastian Lawrence

Canaccord Genuity                                                                            +44 20 7523 4606

Simon Bridges / Emma Gabriel

FTI Consulting LLP                                                                            +44 20 3727 1000

Matt Dixon / Harry Staight

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFKFDDNBKDFFK